News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
02-Apr-2001 - Abgenix, Inc. (Nasdaq: ABGX) announced today that it has expanded its relationship with Chiron Corporation ("Chiron") (Nasdaq: CHIR). Under the new agreement, Chiron will use Abgenix’s XenoMouse ™ technology to generate fully human monoclonal antibody therapies against multiple cancer-specific ...
30-Mar-2001 - Abgenix, Inc. (Nasdaq: ABGX) announced today that it has expanded its relationship with Chiron Corporation ("Chiron") (Nasdaq: CHIR). Under the new agreement, Chiron will use Abgenix’s XenoMouse ™ technology to generate fully human monoclonal antibody therapies against multiple cancer-specific ...
08-Mar-2001 - Abgenix, Inc. (Nasdaq: ABGX) presented the results of its Phase IIa clinical trial of ABX-IL8 for use in the treatment of moderate-to-severe psoriasis at a meeting of the American Academy of Dermatology (AAD) in Washington, D.C. ABX-IL8 is a fully human monoclonal antibody generated with ...
09-Feb-2001 - Abgenix, Inc. (Nasdaq: ABGX) announced today an agreement with Celltech Group plc (LSE: CCH; NYSE: CLL) which provides Celltech with rights to use Abgenix’s proprietary high throughput antibody selection technology to rapidly identify high affinity candidates from antibodies Celltech will ...
05-Feb-2001 - Lexicon Genetics Incorporated (Nasdaq: LEXG) and Abgenix, Inc. (Nasdaq: ABGX) announced today that Lexicon has delivered to Abgenix, thirteen (13) human antigens for antibody development as part of the companies’ drug discovery alliance. This marks the first of many antigens to be delivered to ...
30-Jan-2001 - Abgenix, Inc. (Nasdaq: ABGX) today announced that it has entered into a manufacturing supply agreement with Lonza Biologics (Lonza) wherein Lonza will make available exclusively to Abgenix, for a period of five years, a cell culture production suite within its facility in Slough, England. The ...
09-Jan-2001 - Abgenix, Inc. (Nasdaq: ABGX) and Dyax Corp. (Nasdaq: DYAX) announced today that they have entered into a collaboration to develop new technology for discovering and developing human antibody therapeutics. Under the collaboration, the Companies will combine Abgenix’s XenoMouse™ technology with ...
08-Jan-2001 - Abgenix, Inc. (Nasdaq: ABGX) today announced the promotion of Raymond M. Withy, Ph.D. to President and Chief Operating Officer of Abgenix, succeeding R. Scott Greer, who will continue as Chief Executive Officer and Chairman of the Board. Dr. Withy has served as Chief Business Officer of the ...
01-Dec-2000 - Abgenix, Inc. (Nasdaq: ABGX), and SangStat (Nasdaq: SANG) reported today that ABX-CBL has been granted orphan drug designation for the treatment of acute graft-versus-host disease by the U.S. Food and Drug Administration (FDA). ABX-CBL, an antibody developed by Abgenix, is a murine anti-CD147 ...
© 1997-2024 LUMITOS AG, All rights reserved